Leveraging their expertise in genetics, biochemistry, and proprietary technologies, T3S Technologies has developed genetically engineered bacterial cells that revolutionize biologics manufacturing. These cells enable the expression and optimization of difficult-to-produce recombinant protein products, paving the way for improved treatments for chronic diseases. By expanding biologics manufacturing capabilities and streamlining the production process, researchers can enhance protein production and accelerate advancements in the field.